end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AllocatedShareBasedCompensationExpense,Assets,AssetsCurrent,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleSecuritiesDebtSecurities,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConvertiblePreferredStockSharesIssuedUponConversion,Depreciation,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InvestmentIncomeInterest,LeaseCost,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseExpense,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherLiabilitiesCurrent,OtherOperatingActivitiesCashFlowStatement,PaymentsOfStockIssuanceCosts,PaymentsToAcquireInvestments,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,RedeemablePreferredStockDividends,ResearchAndDevelopmentExpense,RestrictedCashEquivalentsNoncurrent,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares,ShortTermInvestments,ShortTermLeaseCost,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityLiquidationPreference,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,VariableLeaseCost,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DefinedContributionPlanEmployerDiscretionaryContributionAmount,DefinedContributionPlanEmployerMatchingContributionPercent,DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent,DividendsCommonStock,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCreditsResearch,Investments,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,NumberOfOperatingSegments,PaymentsOfDividendsCommonStock,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,SharePrice,TemporaryEquityParOrStatedValuePerShare,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense,ValuationAllowanceDeferredTaxAssetChangeInAmount
2020-12-31,2021-03-25,10-K,VOR BIOPHARMA INC.,VOR,CIK0001817229,USD,2361000.0,6260000.0,1097000.0,726000.0,2158000.0,1342000.0,,1342000.0,75908000.0,49106000.0,,,444000.0,48539000.0,50098000.0,42073000.0,0.0001,420000000.0,893231.0,505074.0,1000.0,18508363.0,605000.0,-230.57,2727000.0,,0.0,0.0,0.0,0.0,11748000.0,5820000.0,393000.0,2503000.0,-606000.0,29000.0,2324000.0,27637000.0,75908000.0,10207000.0,82526000.0,-4161000.0,-36292000.0,-43337000.0,-49262000.0,29000.0,43366000.0,-43366000.0,1780000.0,782000.0,18293000.0,863000.0,17430000.0,703000.0,17117000.0,0.094,62000.0,100000.0,3398000.0,723000.0,,,,4161000.0,0.0001,0.0,0.0,0.0,467000.0,,82267000.0,259000.0,-43337000.0,5454000.0,4728000.0,5925000.0,31618000.0,1559000.0,1559000.0,-61224000.0,17899000.0,1342000.0,,,,2.19,32086000.0,5084679.0,3.79,,,,388157.0,0.0,309000.0,-59065000.0,,,,359000.0,107336000.0,111628000.0,338973691.0,251714086.0,251714086.0,235000.0,213658.0,23256000.0,0.0,4842000.0,11515000.0,3113000.0,2851000.0,177000.0,659000.0,18414000.0,4842000.0,,,,0.0,0.21,0.326,,-0.002,0.06,0.058,0.0,,,,,,,,,,0.0,,,,,2.59,159197.0,,,,0.0001,0.0,0.0,,14100000.0
2021-03-31,2021-05-06,10-Q,VOR BIOPHARMA INC.,VOR,CIK0001817229,USD,2406000.0,4395000.0,997000.0,1037000.0,342130000.0,891000.0,17132000.0,891000.0,292939000.0,266265000.0,,,149000.0,262567000.0,264126000.0,214028000.0,0.0001,400000000.0,37129729.0,36770010.0,4000.0,,311000.0,-0.67,1598000.0,13900000.0,0.0,0.0,0.0,0.0,4789000.0,-2444000.0,,-141000.0,3131000.0,7000.0,921000.0,25752000.0,292939000.0,8631000.0,232848000.0,-1171000.0,-17649000.0,-13723000.0,-14951000.0,7000.0,13730000.0,-13730000.0,747000.0,322000.0,18276000.0,1155000.0,17121000.0,442000.0,16796000.0,0.0936,51000.0,92000.0,2582000.0,675000.0,,1744000.0,,1171000.0,0.0001,10000000.0,0.0,0.0,3606000.0,189199000.0,45375000.0,18000.0,-13723000.0,6774000.0,5737000.0,1228000.0,8941000.0,,1559000.0,-74947000.0,,891000.0,989860.0,1.8,394934.0,15.27,206544000.0,5441397.0,5.16,1.31,22.51,40772000.0,359719.0,,52000.0,267187000.0,38216.0,152711000.0,186308000.0,65000.0,,,,,,122000.0,22263994.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-09,10-Q,VOR BIOPHARMA INC.,VOR,CIK0001817229,USD,2369000.0,4293000.0,573000.0,1391000.0,343421000.0,1067000.0,,1067000.0,275143000.0,249265000.0,75118000.0,75118000.0,,169516000.0,171075000.0,,0.0001,400000000.0,37142950.0,36885372.0,4000.0,,400000.0,-0.5,2317000.0,14100000.0,,,,,5410000.0,,,,,10000.0,1069000.0,25035000.0,275143000.0,8304000.0,,,,-18370000.0,-18370000.0,10000.0,18380000.0,-18380000.0,757000.0,,17895000.0,1164000.0,16731000.0,,16356000.0,0.094,288000.0,65000.0,2111000.0,478000.0,,,,,0.0001,10000000.0,0.0,0.0,4566000.0,,,,,7243000.0,5852000.0,,12970000.0,1559000.0,,-93317000.0,,,,,,,,,,,,,257578.0,75118000.0,,250108000.0,,,,,,,,,,312000.0,36843087.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,VOR BIOPHARMA INC.,VOR,CIK0001817229,USD,1957000.0,5676000.0,861000.0,1763000.0,344824000.0,1154000.0,,1154000.0,258632000.0,232072000.0,82934000.0,82934000.0,,143034000.0,145447000.0,,0.0001,400000000.0,37247414.0,37018282.0,4000.0,,300000.0,-0.5,3841000.0,14000000.0,,,,,5677000.0,,,,,48000.0,1098000.0,25675000.0,258632000.0,9210000.0,,,,-18554000.0,-18554000.0,48000.0,18602000.0,-18602000.0,756000.0,,17612000.0,1147000.0,16465000.0,,16016000.0,0.094,173000.0,749000.0,2141000.0,430000.0,,,,,0.0001,10000000.0,0.0,0.0,5355000.0,,,,,7753000.0,5990000.0,,12925000.0,2413000.0,,-111871000.0,,,,,,,,,,,,,229132.0,82934000.0,,232957000.0,,,,,,,,,,342000.0,36934311.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-14,10-K,VOR BIOPHARMA INC.,VOR,CIK0001817229,USD,1545000.0,6335000.0,743000.0,2084000.0,346382000.0,4314000.0,17132000.0,4315000.0,242590000.0,214399000.0,87668000.0,87668000.0,194000.0,119801000.0,122214000.0,72116000.0,0.0001,400000000.0,37375428.0,37174741.0,4000.0,,1434000.0,-2.1,4178000.0,13100000.0,,,0.0,0.0,21489000.0,405000.0,-2559000.0,668000.0,6363000.0,119000.0,4168000.0,26327000.0,242590000.0,10153000.0,232911000.0,-91651000.0,-69144000.0,-68899000.0,-70127000.0,119000.0,69018000.0,-69018000.0,3017000.0,3017000.0,18013000.0,1839000.0,16174000.0,2559000.0,15670000.0,0.094,617000.0,2094000.0,3255000.0,434000.0,174000.0,2215000.0,87757000.0,3894000.0,0.0001,10000000.0,0.0,0.0,4836000.0,189198000.0,45375000.0,553000.0,-68899000.0,8937000.0,6853000.0,1228000.0,47529000.0,2413000.0,,-130123000.0,35000.0,4315000.0,1669852.0,4.15,730884.0,13.14,38000000.0,5086792.0,6.17,,19.46,14384000.0,200687.0,87668000.0,52000.0,216263000.0,,152711000.0,186308000.0,,,,,,,1099000.0,33433214.0,44015000.0,0.0,4614000.0,25060000.0,6913000.0,5675000.0,529000.0,972000.0,39401000.0,4614000.0,600000.0,1.0,0.06,0.0,0.21,0.305,0.003,-0.003,0.06,0.041,,26445000.0,11665000.0,3410000.0,2970000.0,2883000.0,2799000.0,2718000.0,8432000.0,1.0,0.0,0.0,3100000.0,126.0,285698.0,,,18.0,4.1,,,0.0,0.0,0.0,21000000.0
